Type
. Rabies, tetanus, leprosy, and malaria. Handbook of clinical neurology. 2014;121:1501-20.
Type
. Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. Cellular reprogramming [Internet]. 2014;16(1):9-17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920758/pdf/cell.2013.0064.pdf
Type
. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. 2014;37(2):593-8.
Type
. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation. European journal of immunology. 2014;44(2):431-9.
Type
. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. International journal of dermatology. 2014;53(1):109-13.
Type
. Immunocytochemical detection of mycobacterial antigen in extrapulmonary tuberculosis. Diagnostic cytopathology. 2014;42(5):391-5.
Type
. Interleukin-17F single-nucleotide polymorphism (7488T>C) and its association with susceptibility to leprosy. International journal of immunogenetics. 2014;41(2):131-7.
Type
. Tuberculosis and leprosy in Italy: new skeletal evidence. Homo : internationale Zeitschrift fur die vergleichende Forschung am Menschen. 2014;65(1):13-32.
Type
. The burden of leprosy in children and adolescents in rural southern Ethiopia. Paediatrics and international child health. 2014;34(1):24-8.
Type
. Drug resistance in patients with leprosy in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Internet]. 2014;58(1):72-3. Available from: https://academic.oup.com/cid/article/58/1/72/372994